Simoa® Semi-Quantitative SARS-CoV-2 IgG Antibody Test (EUA) | Request More Information 


Speak to our team today!

By submitting this form, you agree to Quanterix’s Terms of Use and Privacy Policy.  In addition, you agree to receive information regarding Quanterix products and services.  You will be able to unsubscribe at any time.

Follow Us!

  

Immunoassay for the qualitative and semi-quantitative determination of antibodies to the SARS-CoV-2 spike protein. For use under the Emergency Use Authorization (EUA) only.

The Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test is an automated paramagnetic microbead-based immunoassay intended for qualitative and semi-quantitative detection of IgG antibodies to SARS-CoV-2 in human serum and dipotassium EDTA plasma using the Quanterix HD-X immunoassay system. The Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARSCoV-2, indicating recent or prior infection.

If you would like to find out more about achieving a higher-sensitivity measure of SARS-Co-V 2 IgG, fill out our contact form and someone from our team will get in touch with you!